Source:http://linkedlifedata.com/resource/pubmed/id/12473386
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2002-12-10
|
pubmed:abstractText |
The present study was performed to gain insight into the role of p53 and p21(WAF1) on the cytotoxicity of the purine analogue cladribine (2-CdA) on cancer cells. Drug sensitivity, cell cycle distribution and drug-induced cell death were compared in three lines derived from the colorectal carcinoma HCT116: the p53+/+ cell line containing wild-type p53 and the p53-/- and p21(WAF1)-/- lines, in which both alleles of p53 or p21(WAF1) were deleted by homologous recombination, respectively. p53-/- and p21(WAF1)-/- cells were significantly more resistant to the cytotoxic effects of 2-CdA than the p53+/+ cells. p53+/+ cells and p21(WAF1)-/-, but not p53-/- cells, displayed wt-p53 protein accumulation and arrested in S-phase after exposure to 2-CdA. mRNA analysis of the transporter hENT1 and of enzymes involved in drug metabolism did not show alterations which might explain a drug-resistant phenotype in the p53-/- or p21(WAF1)-/- cells. Exposure of p53+/+ cells to 2-CdA resulted in expression of p21(WAF1) mRNA and protein, enhanced expression of uncleaved PARP-1, and a higher degree both of apoptosis and necrosis than in p53-/- and p21(WAF1)-/- cells exposed to 2-CdA. Addition of the specific PARP-1 inhibitor 3-AB to 2-CdA-treated cells rendered p53+/+ cells resistant to this drug. Bax levels were reduced in the p53-/- while they increased in the p53+/+ line and remained stable in the p21(WAF1)-/- cells. We conclude that p53 and p21(WAF1) status of cancer cells influences their sensitivity to 2-CdA cytotoxicity. This may involve alterations in the apoptotic cascade as well as in PARP-1-dependent cell death.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/CDKN1A protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cladribine,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor...,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclins,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0006-2952
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
121-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12473386-Antineoplastic Agents,
pubmed-meshheading:12473386-Apoptosis,
pubmed-meshheading:12473386-Blotting, Northern,
pubmed-meshheading:12473386-Blotting, Western,
pubmed-meshheading:12473386-Cell Cycle,
pubmed-meshheading:12473386-Cell Survival,
pubmed-meshheading:12473386-Cladribine,
pubmed-meshheading:12473386-Cyclin-Dependent Kinase Inhibitor p21,
pubmed-meshheading:12473386-Cyclins,
pubmed-meshheading:12473386-Drug Screening Assays, Antitumor,
pubmed-meshheading:12473386-Gene Expression,
pubmed-meshheading:12473386-Humans,
pubmed-meshheading:12473386-Necrosis,
pubmed-meshheading:12473386-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:12473386-Tumor Cells, Cultured,
pubmed-meshheading:12473386-Tumor Suppressor Protein p53
|
pubmed:year |
2003
|
pubmed:articleTitle |
Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribine.
|
pubmed:affiliation |
INSERM 453. 8 Avenue Rockefeller, 69373 Lyon Cedex 08, France. fgalma@rockefeller.univ-lyon1.fr
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|